Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
HKSE:02252'
s OCF Yield % Range Over the Past 10 Years
Min: -10.11 Med: -2.71 Max: -0.07
Current: -0.09
During the past 7 years, the highest OCF Yield % of Shanghai MicroPort MedBot (Group) Co was -0.07%. The lowest was -10.11%. And the median was -2.71%.
HKSE:02252's OCF Yield % is ranked worse than 58.35% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 1.565
vs HKSE:02252: -0.09
Shanghai MicroPort MedBot (Group) Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Shanghai MicroPort MedBot (Group) Co OCF Yield % Related Terms
Shanghai MicroPort MedBot (Group) Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai MicroPort MedBot (Group) Co OCF Yield % Chart
HKSE:02252 vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, Shanghai MicroPort MedBot (Group) Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai MicroPort MedBot (Group) Co OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort MedBot (Group) Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Shanghai MicroPort MedBot (Group) Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai MicroPort MedBot (Group) Co (HKSE:02252) has a OCF Yield % of -0.09 as of Aug. 14, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Shanghai MicroPort MedBot (Group) Co and its competitors. According to the industry distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #496 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 58.4%.
Is Shanghai MicroPort MedBot (Group) Co's OCF Yield % too high?
Shanghai MicroPort MedBot (Group) Co's current OCF Yield % is -0.09. Based on the distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #496 out of 850 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shanghai MicroPort MedBot (Group) Co has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai MicroPort MedBot (Group) Co's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #496 out of 850 companies for OCF Yield %. This places Shanghai MicroPort MedBot (Group) Co in the lower half of its industry. The industry median OCF Yield % is 1.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.57, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Shanghai MicroPort MedBot (Group) Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai MicroPort MedBot (Group) Co's current OCF Yield % is -0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai MicroPort MedBot (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co (HKSE:02252) is currently considered Possible Value Trap. The stock's GF Value™ is HK$81.81, compared to a current price of HK$25.48 — trading 68.9% below its estimated fair value. The current OCF Yield % is -0.09. Shanghai MicroPort MedBot (Group) Co's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Shanghai MicroPort MedBot (Group) Co (HKSE:02252), the current OCF Yield % is -0.09 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co stock appears to be undervalued.
The current stock price of HK$25.48 is trading 68.9% below its estimated GF Value™ of HK$81.81.
GuruFocus considers Shanghai MicroPort MedBot (Group) Co to be Possible Value Trap.
Key valuation signals for HKSE:02252:
OCF Yield %: -0.09
GF Value™: HK$81.81 vs. price of HK$25.48 (68.9% below fair value)
No single metric tells the full story. See the HKSE:02252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. The business of the company covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives maximum revenue from the People's Republic of China.
45GF Score
Get the complete analysis for HKSE:02252
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02252 has been successfully added to your 
